Moberg Pharma AB ; Telefon: 08-522 307 00; Fax: 08-735 20 29; Email: info@mobergpharma.se; Adress: Moberg Pharma AB (Publ), Gustavslundsvägen 42, 5 tr. 167 51 Bromma

30 Oct 2015 Swedish speciality pharmaceutical company Moberg Pharma has brought its flagship product, Kerasal Nail, to China, capitalising on the

Moberg Pharma to divest its OTC business for USD 155m The announcement that Moberg Pharma will divest its OTC business is a complete turnaround for the company. Over the last few years, Moberg Pharma has established a leading position for its products in the commercial operations. During FY 2018 the Moberg Pharma AB is a pharmaceutical company. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. It has a single operating segment, the development, and commercialization of medical products. It derives most of its revenues from the United States of America.

Moberg Pharma: Announcement of terms for the fully guaranteed rights issue in Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products for skin .. Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. It offers products through the DongKoo Bio & Pharma · News & Notice · Search for Products · New Product · Advanced facilities · CEO Message · Customized CMO · DongKoo, People. Stock analysis for Moberg Pharma AB (MOB:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Our brands include Kerasal Nail®, Kerasal® and Emtrix®. The Nalox™/Naloc™ and Cremolan® brands are owned by our partners.

2021-04-01

It derives most of its revenues from the United States of America. Moberg Pharma’s fungal nail product approved in China Tue, Jan 27, 2015 08:30 CET. Moberg Pharma AB (OMX: MOB) today announced that its partner, Menarini Asia-Pacific, has received approval for Moberg’s fungal nail product in China. Launch preparations in several markets are progressing ahead of plan.

As of April 2019, Moberg Pharma focuses on the commercialization of its clinical pipeline with a combined peak sales potential estimated at USD 350–700 million. MOB-015 is a next generation nail fungus treatment, and BUPI is a novel treatment for oral pain relief in association with inflammation and ulceration of the oral mucous membranes (oral mucositis or OM), a serious

www.newskinproducts.com 307 00; Fax: +46.8-735 20 29; Email: info@mobergpharma.se; Address: Moberg Pharma AB (Publ),; Gustavslundsvägen 42, 5 tr. Moberg Pharma AB - Head Office Telephone: 08-522 30 700. Fax: 08-735 20 29. Email: info@mobergpharma.se.

Moberg Pharma AB is a pharmaceutical company. The company develops and markets consumer healthcare products that relieve pain and treat skin Moberg Derma's first product Nalox™/Emtrix® - for nail disorders - became the Nordic market leader directly after launch in autumn 2010 and international Products manufactured by Moberg Pharma. Emtrix (Urea) Skin >> Skin and nail infections. MIMS Clinics. Prescribing news and resources for key therapeutic Prestige Brands Holdings, Inc. to Sell Three Brands to Moberg Pharma AB of three of its non-core over-the-counter healthcare products to Moberg Pharma AB Find the latest Moberg Pharma AB (MOB. Moberg Pharma: Announcement of terms for the fully guaranteed rights issue in Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products for skin .. Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products.
Sfi hässleholm öppettider

December 14, 2020. The entire EU OTC market is a jungle, with >40 products on the shelves.

Its product portfolio includes products for the treatment of skin The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. Profile.
Swedish pro wrestling

Moberg Pharma AB researches and produces topical treatments for skin conditions. The Company is researching creams for nail fungus, dry and scaly skin, anal fissures, and actinic keratosis.

Moberg Pharma |. Moberg Pharma is a rapidly growing Swedish pharmaceutical company commercializing proprietary, acquired and licensed products in the global market. Initially, the company specialized in the treatment of skin diseases, with a focus on treatments for nail fungus.